Table 1.
Demographic and Epidemiologic Features of severe COVID-19 Patients on admission.
| No. (%) |
P Value | |||
|---|---|---|---|---|
| Total(n = 311) | Nonprobioctics(n = 188) | Probiotics(n = 123) | ||
| Age | 60.10 ± 12.37 | 60.20 ± 12.67 | 62.019 ± 10.88 | 0.196 |
| Sex (Male) | 150(48.23%) | 83(44.15%) | 67(54.47%) | 0.075 |
| Comorbidities | 184(59.16%) | 114 (60.64%) | 72 (58.54%) | 0.712 |
| Chronic bronchitis | 13(4.18%) | 11(5.85%) | 2(1.63%) | 0.069 |
| Hypertension | 109(35.05%) | 63(33.51%) | 46(37.40%) | 0.482 |
| Diabetes | 60(19.29%) | 34(18.09%) | 26(21.14%) | 0.497 |
| Heart disease | 48(15.43%) | 34(18.09%) | 14(11.38%) | 0.110 |
| Renal failure | 10(3.22%) | 8(4.26%) | 2(1.63%) | 0.199 |
| Liver failure | 8(2.57%) | 6(3.19%) | 2(1.63%) | 0.394 |
| Tumor | 24(7.72%) | 13(6.91%) | 11(8.94%) | 0.499 |
| Time from onset of illness to inpatients | 13.00 ± 6.13 | 12.3 ± 5.88 | 13.1 ± 6.41 | 0.323 |
| Fever | 254(81.67%) | 158 (84.04%) | 96(78.05%) | 0.182 |
| Cough | 226(72.67%) | 138(73.40%) | 88(71.54%) | 0.719 |
| Cough phlegm | 115(36.98%) | 78(41.49%) | 37(30.08%) | 0.042* |
| Shortness of breath | 141(45.33%) | 84(44.68%) | 57(46.34%) | 0.774 |
| Diarrhea | 67(21.54%) | 37(19.68%) | 30(24.39%) | 0.323 |
Data are presented as mean ± SD, n (%).
*
Significant at P < 0.05.